Related references
Note: Only part of the references are listed.The role of orphan G protein-coupled receptors in the pathophysiology of multiple sclerosis: A review
Mohaddeseh Sadat Alavi et al.
LIFE SCIENCES (2019)
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination
Giusy T. Coppolino et al.
GLIA (2018)
Identification of novel GPR17-agonists by structural bioinformatics and signaling activation
Konda Mani Saravanan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination
Changqing Lu et al.
SCIENTIFIC REPORTS (2018)
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17
Younis Baqi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural Probing and Molecular Modeling of the A3 Adenosine Receptor: A Focus on Agonist Binding
Antonella Ciancetta et al.
MOLECULES (2017)
Achievements and obstacles of remyelinating therapies in multiple sclerosis
Martin Stangel et al.
NATURE REVIEWS NEUROLOGY (2017)
Multiple sclerosis animal models: a clinical and histopathological perspective
Markus Kipp et al.
BRAIN PATHOLOGY (2017)
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights
Chiara Parravicini et al.
CELLULAR SIGNALLING (2016)
Homology modeling of a Class A GPCR in the inactive conformation: A quantitative analysis of the correlation between model/template sequence identity and model accuracy
Stefano Costanzi et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17
Marta Fumagalli et al.
NEUROPHARMACOLOGY (2016)
Epidemiology of multiple sclerosis
E. Leray et al.
REVUE NEUROLOGIQUE (2016)
Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description
Francesca Spyrakis et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands
Marcel Bermudez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The Ubiquitin Ligase Mdm2 Controls Oligodendrocyte Maturation by Intertwining mTOR with G Protein-Coupled Receptor Kinase 2 in the Regulation of GPR17 Receptor Desensitization
Marta Fumagalli et al.
GLIA (2015)
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
Julia Marschallinger et al.
NATURE COMMUNICATIONS (2015)
Advancements in therapeutically targeting orphan GPCRs
Jennifer A. Stockert et al.
FRONTIERS IN PHARMACOLOGY (2015)
Oxysterols act as promiscuous ligands of class-A GPCRs: In silico molecular modeling and in vitro validation
Cristina Sensi et al.
CELLULAR SIGNALLING (2014)
The Regulated Expression, Intracellular Trafficking, and Membrane Recycling of the P2Y-like Receptor GPR17 in Oli-neu Oligodendroglial Cells
Alessandra Fratangeli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury
Heike Franke et al.
PURINERGIC SIGNALLING (2013)
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist
Stephanie Hennen et al.
SCIENCE SIGNALING (2013)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Accurate multiple sequence alignment of transmembrane proteins with PSI-Coffee
Jia-Ming Chang et al.
BMC BIOINFORMATICS (2012)
The innate immune system in demyelinating disease
Lior Mayo et al.
IMMUNOLOGICAL REVIEWS (2012)
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
Robert J. Fox et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Central nervous system remyelination in culture - A tool for multiple sclerosis research
Hui Zhang et al.
EXPERIMENTAL NEUROLOGY (2011)
The GPR17 Receptor in NG2 Expressing Cells: Focus on In Vivo Cell Maturation and Participation in Acute Trauma and Chronic Damage
Enrica Boda et al.
GLIA (2011)
Phenotypic Changes, Signaling Pathway, and Functional Correlates of GPR17-expressing Neural Precursor Cells during Oligodendrocyte Differentiation
Marta Fumagalli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases
Ivano Eberini et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands
S. Daniele et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Axonal Damage in Multiple Sclerosis
Jeffery D. Haines et al.
MOUNT SINAI JOURNAL OF MEDICINE (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors
Philip G. Strange
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Chronic Progressive Multiple Sclerosis - Pathogenesis of Neurodegeneration and Therapeutic Strategies
Dirk Fitzner et al.
CURRENT NEUROPHARMACOLOGY (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach
Chiara Parravicini et al.
BMC STRUCTURAL BIOLOGY (2010)
The diagnosis of multiple sclerosis and the clinical subtypes
Barrie J. Hurwitz
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2009)
The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury
Stefania Ceruti et al.
BRAIN (2009)
The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination
Ying Chen et al.
NATURE NEUROSCIENCE (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
GPR17: Molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors
Chiara Parravicini et al.
BMC BIOINFORMATICS (2008)
The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair
Davide Lecca et al.
PLOS ONE (2008)
Type III neuregulin-1 promotes oligodendrocyte myelination
Carla Taveggia et al.
GLIA (2008)
Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space
Marwen Naim et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
Paolo Ciana et al.
EMBO JOURNAL (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes
JR Chan et al.
NEURON (2004)
Generalized born model: Analysis, refinement, and applications to proteins
M Wojciechowski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2004)
Property distribution of drug-related chemical databases
TI Oprea
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2000)
Share Paper
